Moneycontrol
HomeNewsIndiaIndia focussed on mitigating COVID-19's negative economic impact on talent abroad: Jaishankar
Trending Topics

India focussed on mitigating COVID-19's negative economic impact on talent abroad: Jaishankar

Addressing the third edition of the Annual Conference of Protectors of Emigrants via video-conferencing, he said the protectors of emigrants must also rise to the challenge of reviving the post-COVID economy and engage with the post-COVID world.

June 15, 2020 / 13:53 IST
Story continues below Advertisement

India has been engaged with foreign governments to ensure the welfare of prospective migrants, and is currently focussed on mitigating the negative economic consequences of the COVID-19 pandemic on Indian talent abroad, External Affairs Minister S Jaishankar said on Monday.

Addressing the third edition of the Annual Conference of Protectors of Emigrants via video-conferencing, he said the protectors of emigrants must also rise to the challenge of reviving the post-COVID economy and engage with the post-COVID world.

Story continues below Advertisement

"Our government has accorded the highest priority to promoting the interests of Indian emigrants for the last six years," Jaishankar said.

The government's focus has been to provide better opportunities and welfare measures to prospective migrants, he added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show